Evidence map›Paper›PMID 38189947›Full record

ArticleWorld journal of urology2024

The landscape of penile cancer research in Germany and Austria: a survey among professors in academic centers holding chair positions and results of a literature search.

Semih Sarcan, Ingmar Wolff, Lukas Lusuardi, Anton Kravchuk, Jens Wiegland, Abdulbaki Yakac, Christian Thomas, Maximilian Burger, Christian Gilfrich, Steffen Lebentrau and 3 more

Abstract read
PubMed Publisher
In one paragraph

Article in World journal of urology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Semih Sarcan *Department of Urology, University Hospital Schleswig-Holstein, Lübeck, Germany.
Ingmar Wolff *Department of Urology, University Medicine Greifswald, Greifswald, Germany.
Lukas LusuardiDepartment of Urology and Andrology, Paracelsus Medical University, Salzburg, Austria.
Anton KravchukDepartment of Urology, St. Elisabeth Hospital Straubing, Brothers of Mercy Hospital, Straubing, Germany.
Jens WieglandDepartment of Urology, Medical Faculty Carl Gustav Carus, TU Dresden, Dresden, Germany.
Abdulbaki YakacDepartment of Urology, Medical Faculty Carl Gustav Carus, TU Dresden, Dresden, Germany.
Christian ThomasDepartment of Urology, Medical Faculty Carl Gustav Carus, TU Dresden, Dresden, Germany.
Maximilian BurgerDepartment of Urology, University of Regensburg, Caritas St. Josef Medical Center, Regensburg, Germany.
Christian GilfrichDepartment of Urology, St. Elisabeth Hospital Straubing, Brothers of Mercy Hospital, Straubing, Germany.
Steffen LebentrauDepartment of Urology, Otto-Von-Guericke-University Magdeburg, Magdeburg, Germany.
Sascha AhyaiDepartment of Urology, Medical University of Graz, Graz, Austria.
Axel MerseburgerDepartment of Urology, University Hospital Schleswig-Holstein, Lübeck, Germany.
Matthias MayDepartment of Urology, St. Elisabeth Hospital Straubing, Brothers of Mercy Hospital, Straubing, Germany. matthias.may@klinikum-straubing.de.ORCID http://orcid.org/0000-0003-3896-0405

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundResearch on penile cancer (PeCa) is predominantly conducted in countries with centralized treatment of PeCa-patients. In Germany and Austria (G + A), no state-regulated centralization is established, and no information is available on how PeCa-research is organized.

methodsCurrent research competence in PeCa was assessed by a 36-item questionnaire sent to all chairholders of urological academic centers in G + A. Based on PubMed records, all scientific PeCa-articles of 2012-2022 from G + A were identified. Current research trends were assessed by dividing the literature search into two periods (P1: 2012-2017, P2: 2018-2022). A bibliometric analysis was supplemented.

resultsResponse rate of the questionnaire was 75%, a median of 13 (IQR: 9-26) PeCa-patients/center was observed in 2021. Retrospective case series were conducted by 38.9% of participating clinics, while involvement in randomized-controlled trials was stated in 8.3% and in basic/fundamental research in 19.4%. 77.8% declared an interest in future multicenter projects. 205 PeCa-articles were identified [median impact factor: 2.77 (IQR: 0.90-4.37)]. Compared to P1, P2 showed a significant increase in the median annual publication count (29 (IQR: 13-17) vs. 15 (IQR: 19-29), p < 0.001), in multicenter studies (79.1% vs. 63.6%, p = 0.018), and in multinational studies (53% vs. 28.9%, p < 0.001); the proportion of basic/fundamental research articles significantly declined (16.5% vs. 28.9%, p = 0.041). Four of the top-5 institutions publishing PeCa-articles are academic centers. Bibliometric analyses revealed author networks, primary research areas in PeCa, and dominant journals for publications.

conclusionsGiven the lack of centralization in G + A, this analysis highlights the need for research coordination within multicenter PeCa-projects. The decline in basic/fundamental research should be effectively addressed by the allocation of funded research projects.

Indexed as

Penile NeoplasmsAustriaGermanyHumansMaleRetrospective StudiesSurveys and QuestionnairesBibliometric analysisPenile carcinomaPenile neoplasmProposal for a randomized-controlled trialResearch competenceReview of the literature

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.